DS20362725 is a selective estrogen-related receptor alpha (ERRalpha) agonist that binds to ERRalpha and enhances its transcriptional activity while preventing ERRalpha from binding to its repressor, receptor-interacting protein 140 (RIP140), commonly used in the study of metabolic disorders.